213 related articles for article (PubMed ID: 28724893)
1. The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis.
Li X; Li T; Liu Z; Gou S; Wang C
Sci Rep; 2017 Jul; 7(1):5825. PubMed ID: 28724893
[TBL] [Abstract][Full Text] [Related]
2. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
[TBL] [Abstract][Full Text] [Related]
3. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis.
Wan G; Sun X; Li F; Wang X; Li C; Li H; Yu X; Cao F
Cell Physiol Biochem; 2018; 49(3):837-847. PubMed ID: 30184547
[TBL] [Abstract][Full Text] [Related]
4. The addition of metformin to systemic anticancer therapy in advanced or metastatic cancers: a meta-analysis of randomized controlled trials.
Kim HS; Kim JH; Jang HJ; Lee J
Int J Med Sci; 2020; 17(16):2551-2560. PubMed ID: 33029097
[TBL] [Abstract][Full Text] [Related]
5. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
6. Metformin and pancreatic cancer survival: Real effect or immortal time bias?
Wei M; Liu Y; Bi Y; Zhang ZJ
Int J Cancer; 2019 Oct; 145(7):1822-1828. PubMed ID: 30848544
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis.
Zhou DC; Gong H; Tan CQ; Luo JQ
Oncotarget; 2017 Sep; 8(37):62349-62357. PubMed ID: 28977950
[TBL] [Abstract][Full Text] [Related]
8. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
9. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the use of metformin and the risk of pancreatic cancer in patients with diabetes: a systematic review and meta-analysis.
Hu J; Fan HD; Gong JP; Mao QS
BMC Gastroenterol; 2023 Feb; 23(1):50. PubMed ID: 36829129
[TBL] [Abstract][Full Text] [Related]
11. Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.
Xu H; Chen K; Jia X; Tian Y; Dai Y; Li D; Xie J; Tao M; Mao Y
Oncologist; 2015 Nov; 20(11):1236-44. PubMed ID: 26446233
[TBL] [Abstract][Full Text] [Related]
12. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
Li Y; Hu L; Xia Q; Yuan Y; Mi Y
Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
[TBL] [Abstract][Full Text] [Related]
13. No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies.
Wang Y; Liu X; Yan P; Bi Y; Liu Y; Zhang ZJ
Curr Pharm Des; 2019; 25(23):2595-2601. PubMed ID: 31333095
[TBL] [Abstract][Full Text] [Related]
14. Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis.
Xie W; Li T; Yang J; Shang M; Xiao Y; Li Q; Yang J
Oncotarget; 2017 Sep; 8(42):73079-73086. PubMed ID: 29069850
[TBL] [Abstract][Full Text] [Related]
15. Metformin use and survival of lung cancer patients: Meta-analysis findings.
Zhong S; Wu Y; Yan X; Tang J; Zhao J
Indian J Cancer; 2017; 54(1):63-67. PubMed ID: 29199666
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis.
Yang JJ; Hu ZG; Shi WX; Deng T; He SQ; Yuan SG
World J Gastroenterol; 2015 Mar; 21(9):2807-15. PubMed ID: 25759553
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis.
Yao X; Liu H; Xu H
Biomed Res Int; 2021; 2021():5311828. PubMed ID: 34660791
[TBL] [Abstract][Full Text] [Related]
18. The Association between Metformin and Survival of Head and Neck Cancer: A Systematic Review and Meta-Analysis of 7 Retrospective Cohort Studies.
Wang Y; Fu T; Liu Y; Yang G; Yu C; Zhang ZJ
Curr Pharm Des; 2020; 26(26):3161-3170. PubMed ID: 32067604
[TBL] [Abstract][Full Text] [Related]
19. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
Tian S; Lei HB; Liu YL; Chen Y; Dong WG
Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
[TBL] [Abstract][Full Text] [Related]
20. Metformin and prostate cancer mortality: a meta-analysis.
Stopsack KH; Ziehr DR; Rider JR; Giovannucci EL
Cancer Causes Control; 2016 Jan; 27(1):105-13. PubMed ID: 26537119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
